Toronto, Ontario — November 4, 2025 — Leads & Copy — MindBio Therapeutics Corp. has announced a consolidation of its issued and outstanding common shares, effective November 6, 2025. The consolidation will be on the basis of one post-consolidated common share for every 400 pre-consolidated common shares, reducing the number of outstanding shares to approximately 2,044,228. The stock name and symbol (CSE:MBIO) will remain unchanged.
All open orders will be canceled at the close of business on November 5, 2025. Dealers are reminded to re-enter their orders taking into account the share consolidation.
Record Date/Date d’Enregistrement : Le 6 NOV 2025
Anticipated Payment Date/Date de Paiement Prévue : Le 6 NOV 2025
NEW/NOUVEAU CUSIP : 60256C 20 7
NEW/NOUVEAU ISIN : CA 60256C 20 7 6
Old/Vieux CUSIP & ISIN : 60256C108/CA60256C1086
Listings at (416) 367-7340 or E-mail: Listings@thecse.com.
Source: MindBio Therapeutics Corp.
